3-Needle vs 5-Needle of Genicular Nerve Block on Pain and Quality of Life in Knee Osteoarthritis

NCT07853170 — Not applicable, Recruiting, 80 participants, Tanta University

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

A Randomized Controlled Trial Comparing the Effectiveness of 3-Needle vs 5-Needle of Genicular Nerve Block on Pain and Quality of Life in Knee Osteoarthritis

RegistryNCT07853170
StatusRecruiting
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: double, treatment
Enrollment80 (Estimated)
SponsorTanta University (Other)
Conditions3-Needle, 5-Needle, Genicular Nerve Block, Pain, Quality of Life, Knee Osteoarthritis
Interventions3-nerve-targeted group, 5-nerve-targeted group (Other)
Datesstart 2026-10-04, primary completion 2027-09-01 (estimated), completion 2027-09-01 (estimated), first posted 2026-10-01, last updated 2026-10-06
Locations1 site in Egypt

Related Papers Related Patents Related Grants Related Experts
All trials for 3-Needle All trials for 5-Needle All trials of 3-nerve-targeted group All trials of 5-nerve-targeted group

-Summary

This study aims to compare the 3-needle and 5-needle of genicular nerve block on pain and quality of life in Knee osteoarthritis (KOA).

Expand all sections  ·  Collapse all

+Detailed description

Knee osteoarthritis (KOA) is a common musculoskeletal disorder characterized by degeneration of articular cartilage and the subchondral bone. It leads to pain, stiffness, and functional decline in the affected knee joints.

Currently, the classical 3- nerve protocol targeting the superior medial, superior lateral, and inferior medial genicular nerves is the most commonly used technique for radiofrequency procedures.

Therefore, a five-needle Genicular nerve blocks (GNB) technique has been proposed to provide a more comprehensive blockade by targeting additional sensory branches.

+Arms and interventions

ArmTypeInterventionsDescription
Group I (3-nerve-targeted group)ExperimentalOther: 3-nerve-targeted groupPatients will receive 3-nerve protocol.
Group II (5-nerve-targeted group)ExperimentalOther: 5-nerve-targeted groupPatients will receive 5-nerve protocol.
  • 3-nerve-targeted group (Other): Patients will receive 3-nerve protocol.
  • 5-nerve-targeted group (Other): Patients will receive 5-nerve protocol.

+Outcome measures

Primary outcomes

  • Degree of pain [6 months postoperatively]: Each patient will be instructed about postoperative pain assessment with the numeric rating scale (NRS) score. NRS (0 represents "no pain" while 10 represents "the worst pain imaginable").

Secondary outcomes

  • Measurement of Quality of life [6 months postoperatively]: The Western Ontario and McMaster Universities Arthritis Index (WOMAC) is a self-administered health status questionnaire and consists of 24 items divided into 3 subscales: pain (5 items), stiffness (2 items), and physical function (17 items). Accordingly, higher scores on the WOMAC indicate worse pain, stiffness, and functional limitation. The WOMAC will be assessed at each follow-up point
  • Patients' opioid medication use [6 months after treatment]: Patients' opioid medication use will be evaluated before treatment and at 6 months after treatment.
  • Degree of patient satisfaction [6 months postoperatively]: Degree of patient satisfaction will be assessed on a 5-point Likert scale patient satisfaction (1, extremely dissatisfied; 2, unsatisfied; 3, neutral; 4, satisfied; 5, extremely satisfied)

+Eligibility

Sex: All, ages: 18 Years to any

Inclusion Criteria:

* Age ≥18 years.
* Both sexes.
* Patients with unilateral chronic knee pain for more than 3 months.
* Patients received conservative treatment for at least 3 months.
* Diagnosed Knee osteoarthritis (KOA) according to the American College of Rheumatology (ACR) criteria, and grade greater than or equal to Kellgren-Lawrence grade 2.

Exclusion Criteria:

* Chronic knee pain is due to causes other than KOA, such as connective tissue diseases, lumbar radicular neuropathy (spondylolisthesis, spinal stenosis), or sciatic pain.
* Knee effusion.
* Neuro/psychiatric disorders.
* History of intra-articular injection in the prior 3 months.
* Prior knee surgery.
* Active systemic or local knee infections; anticoagulant use.

+Locations (1)

FacilityCityCountryStatus
Tanta UniversityTanta, El-GharbiaEgyptRecruiting

+Publications

  • Results publication: Geng R, Li J, Yu C, Zhang C, Chen F, Chen J, Ni H, Wang J, Kang K, Wei Z, Xu Y, Jin T. Knee osteoarthritis: Current status and research progress in treatment (Review). Exp Ther Med. 2023 Aug 25;26(4):481. doi: 10.3892/etm.2023.12180. eCollection 2023 Oct. PMID 37745043